Edition:
United States

Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

0.32USD
8 Dec 2016
Change (% chg)

$0.02 (+5.49%)
Prev Close
$0.31
Open
$0.34
Day's High
$0.34
Day's Low
$0.31
Volume
200,048
Avg. Vol
174,227
52-wk High
$1.30
52-wk Low
$0.29

PPHM.OQ

Chart for PPHM.OQ

About

Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company. The Company operates through two segments: Peregrine, which is engaged in the research and development of monoclonal antibodies for the treatment of cancer, and Avid, which is engaged in providing contract manufacturing services for third party customers... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $74.19
Shares Outstanding(Mil.): 242.38
Dividend: --
Yield (%): --

Financials

  PPHM.OQ Industry Sector
P/E (TTM): -- 30.04 30.65
EPS (TTM): -0.25 -- --
ROI: -107.23 15.86 15.23
ROE: -119.98 16.96 16.56

BRIEF-Peregrine Pharmaceuticals reports top-line data from phase III SUNRISE trial of Bavituximab

* Press release - Peregrine Pharmaceuticals reports top-line and initial biomarker data from phase III SUNRISE trial of Bavituximab in oral presentation at European Society for Medical Oncology (ESMO) 2016 congress

Oct 10 2016

BRIEF-Peregrine Pharmaceuticals Q4 loss per share $0.05

* Peregrine pharmaceuticals reports financial results for quarter and fiscal year ended april 30, 2016 and recent developments

Jul 14 2016

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥2,390 +0.50
HANALL BIOPHARMA (009420.KS) ₩12,000.00 +350.00
Pfizer Inc. (PFE.N) $30.94 -0.25
Johnson & Johnson (JNJ.N) $110.99 -0.11
Novartis AG (NOVN.S) CHF68.50 -0.25
Merck & Co., Inc. (MRK.N) $60.12 +0.06
Roche Holding Ltd. (ROG.S) CHF220.40 -0.80
Roche Holding Ltd. (RO.S) CHF226.10 +0.90
Bayer AG (BAYGn.DE) €93.17 +3.07
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates